Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in SPRB — Spruce Biosciences, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to SPRB Full portfolio

Position in SPRB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$318,384
+$310,465 QoQ
Shares Held
5,896
+196433.3% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 63 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. SPRB ranks #274 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in SPRB

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $318,384 5,896
2024-06-30 $7,919 15,289
2024-03-31 $12,017 15,289
2023-12-31 $44,796 15,289
2023-09-30 $34,553 15,289
2023-06-30 $32,871 15,289
2022-03-31 $37,018 18,417
2021-12-31 $82,139 18,417
2021-09-30 $110,686 18,417
2021-06-30 $484,597 43,229
2021-03-31 $732,690 44,138
2020-12-31 $980,957 40,352